Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism

NCT: NCT06362928 · WITHDRAWN

NCT IDNCT06362928
StatusWITHDRAWN
Start Date2025-02-11
Completion2026-06-17
SponsorAkura Medical (INDUSTRY)
First posted
Last updated

Brief Summary

This study is a prospective, single-arm, non-randomized, interventional, multicenter feasibility study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subjects with acute pulmonary embolism (PE).

Frequently Asked Questions

What is Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism?

Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism is a clinical trial registered under NCT06362928. Current status: WITHDRAWN.

What is the status of NCT06362928?

The current status of NCT06362928 (Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism) is: WITHDRAWN.

When did Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism start?

Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism started on 2025-02-11.

Related Devices

K251070Akura Thrombectomy SystemAkura Medical

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑